Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2417986
Max Phase: Preclinical
Molecular Formula: C26H34N4O11S2
Molecular Weight: 642.71
Molecule Type: Small molecule
Associated Items:
ID: ALA2417986
Max Phase: Preclinical
Molecular Formula: C26H34N4O11S2
Molecular Weight: 642.71
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CSCCOCCSCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C26H34N4O11S2/c31-13-21(25(35)17-1-5-19(6-2-17)29(37)38)27-23(33)15-42-11-9-41-10-12-43-16-24(34)28-22(14-32)26(36)18-3-7-20(8-4-18)30(39)40/h1-8,21-22,25-26,31-32,35-36H,9-16H2,(H,27,33)(H,28,34)/t21-,22-,25-,26-/m1/s1
Standard InChI Key: UWRAZWKNSJBQQJ-SAZLYLDSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 642.71 | Molecular Weight (Monoisotopic): 642.1665 | AlogP: 0.71 | #Rotatable Bonds: 20 |
Polar Surface Area: 234.63 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.12 | CX Basic pKa: | CX LogP: -0.32 | CX LogD: -0.32 |
Aromatic Rings: 2 | Heavy Atoms: 43 | QED Weighted: 0.07 | Np Likeness Score: -0.54 |
1. Berkov-Zrihen Y, Green KD, Labby KJ, Feldman M, Garneau-Tsodikova S, Fridman M.. (2013) Synthesis and evaluation of hetero- and homodimers of ribosome-targeting antibiotics: antimicrobial activity, in vitro inhibition of translation, and drug resistance., 56 (13): [PMID:23786357] [10.1021/jm400707f] |
Source(1):